Endogenous excitotoxins as possible mediators of ischemic and hypoglycemic brain damage.
D000596:Amino Acids / Q000502:physiology*; D000818:Animals; D001224:Aspartic Acid / Q000502:physiology; D001927:Brain Diseases / Q000473:pathology* / Q000503:physiopathology; D002545:Brain Ischemia / Q000473:pathology* / Q000503:physiopathology; D002118:Calcium / Q000502:physiology; D003342:Corpus Striatum / Q000473:pathology; D005971:Glutamates / Q000502:physiology; D007003:Hypoglycemia / Q000473:pathology* / Q000503:physiopathology; D018377:Neurotransmitter Agents / Q000502:physiology*; D011188:Potassium / Q000502:physiology; D051381:Rats; D018091:Receptors, AMPA; D011955:Receptors, Drug / Q000502:physiology; D016194:Receptors, N-Methyl-D-Aspartate; D017981:Receptors, Neurotransmitter / Q000502:physiology
D000596:Amino Acids; D005971:Glutamates; D018377:Neurotransmitter Agents; D018091:Receptors, AMPA; D011955:Receptors, Drug; D016194:Receptors, N-Methyl-D-Aspartate; D017981:Receptors, Neurotransmitter; D001224:Aspartic Acid; D011188:Potassium; D002118:Calcium